We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Most liver cancers and cases of gliomas, colorectal, breast, endometrial, testicular and pancreatic cancers showed moderate cytoplasmic immunoreactivity. The remaining tumors were basically negative.
A majority of lymphomas, gliomas, breast, colorectal, prostate and endometrial cancers showed moderate staining. Remaining cancers were weakly stained or negative.
Moderate cytoplasmic staining was observed in most malignancies. Several gliomas, colorectal and endometrial cancers were strongly stained.
GENE INFORMATION
Gene name
ATXN2 (HGNC Symbol)
Synonyms
ATX2, SCA2, TNRC13
Description
Ataxin 2 (HGNC Symbol)
Entrez gene summary
This gene belongs to a group of genes that is associated with microsatellite-expansion diseases, a class of neurological and neuromuscular disorders caused by expansion of short stretches of repetitive DNA. The protein encoded by this gene has two globular domains near the N-terminus, one of which contains a clathrin-mediated trans-Golgi signal and an endoplasmic reticulum exit signal. The protein is primarily localized to the Golgi apparatus, with deletion of the Golgi and endoplasmic reticulum signals resulting in abnormal subcellular localization. In addition, the N-terminal region contains a polyglutamine tract. Intermediate length expansions of this tract increase susceptibility to amyotrophic lateral sclerosis, while long expansions of this tract result in spinocerebellar ataxia-2, an autosomal-dominantly inherited, neurodegenerative disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2015]
MEMSAT3 predicted membrane proteins Predicted intracellular proteins Disease related genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)